Armistice Capital’s ContraFect Corporation CFRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-475,000
Closed -$271K 377
2023
Q3
$271K Buy
475,000
+419,258
+752% +$397K ﹤0.01% 187
2023
Q2
$83.6K Sell
55,742
-30,258
-35% -$47.8K ﹤0.01% 192
2023
Q1
$157K Buy
86,000
+34,811
+68% +$164K ﹤0.01% 190
2022
Q4
$393K Buy
+51,189
New +$592K 0.01% 146

Other funds holding CFRX

Armistice Capital's CFRX Position: Q4 2023 in Review

Armistice Capital sold out of ContraFect Corporation (CFRX) in Q4 2023, closing a stake of 475,000 shares — an estimated $271K sold.

Armistice Capital first reported a position in CFRX in Q4 2022 and held it in 4 quarters. The position peaked at $393K in Q4 2022. 2 funds tracked by Wall St. Rank hold CFRX as of Q4 2023.

  • Armistice Capital reported no remaining ContraFect Corporation position as of Q4 2023 after selling out during the quarter.
  • Armistice Capital sold 475,000 ContraFect Corporation shares in Q4 2023, an estimated $271K.
  • Armistice Capital first reported a position in ContraFect Corporation in Q4 2022 and held it in 4 quarters.
  • Armistice Capital's ContraFect Corporation position peaked at $393K in Q4 2022.
  • 2 funds tracked by Wall St. Rank held ContraFect Corporation as of Q4 2023.

Based on Armistice Capital's 13F filing for Q4 2023, filed 13 Feb 2024.